Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2010

View Archived Issues

Netupitant shows promise to treat overactive bladder in preclinical studies

Researchers describe new anti-inflammatory MAPK 14 inhibitors

NGP-328 is selected as clinical candidate for Alzheimer's disease

Stem cell research funding ban does not affect International Stem Cell

SuperGen discovers new inhibitors of tyrosine-protein kinase receptor UFO

Wyeth claims new cannabinoid CB2 receptor agonists

Recordati discloses new metabotropic glutamate mGlu5 receptor antagonists

FDA accepts Sanofi Pasteur's BLA to expand Menactra indication

Organon identifies new TRPV1 ligands

Taisho Pharma describes new histamine H3 receptor antagonists

NIH renews research funding for Homspera in radiation-induced lung injury

Pharming prepares to submit Rhucin BLA to FDA

FDA approves phase II trial protocol of CH-4051 in rheumatoid arthritis

Shire's VPRIV approved in Europe for type 1 Gaucher's disease

Vanda Pharma begins phase III tasimelteon trial in blind patients with N24HSWD

Lotus Pharma initiates phase I trial of (R)-bambuterol in China

FDA issues refuse to file letter for trastuzumab-DM1 BLA

Cardioxyl begins phase IIa trial of CXL-1020 for heart failure

DIDS improves yield and preserves integrity of isolated pancreatic islets

Karo Bio reviews phase III eprotirome program in hypercholesterolemia

Octapharma USA voluntarily withdraws lots of Octagam 5% from market

Actelion to exclusively distribute Basilea's Toctino in Canada

FDA grants orphan drug status to Kineret in CAPS

LIM-0705 reverses tacrolimus-induced metabolic defects in phase Ib trial

FDA approves Novartis' Tekamlo for hypertension

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...